287 related articles for article (PubMed ID: 38391963)
1. Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression.
Fedele M; Cerchia L; Battista S
Cells; 2024 Feb; 13(4):. PubMed ID: 38391963
[TBL] [Abstract][Full Text] [Related]
2. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
3. Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation.
Merkens L; Sailer V; Lessel D; Janzen E; Greimeier S; Kirfel J; Perner S; Pantel K; Werner S; von Amsberg G
J Exp Clin Cancer Res; 2022 Feb; 41(1):46. PubMed ID: 35109899
[TBL] [Abstract][Full Text] [Related]
4. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
Puleo F; Nicolle R; Blum Y; Cros J; Marisa L; Demetter P; Quertinmont E; Svrcek M; Elarouci N; Iovanna J; Franchimont D; Verset L; Galdon MG; Devière J; de Reyniès A; Laurent-Puig P; Van Laethem JL; Bachet JB; Maréchal R
Gastroenterology; 2018 Dec; 155(6):1999-2013.e3. PubMed ID: 30165049
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of PDAC subtype heterogeneity and therapy response.
Espinet E; Klein L; Puré E; Singh SK
Trends Cancer; 2022 Dec; 8(12):1060-1071. PubMed ID: 36117109
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS; Farabaugh SM; Ford HL
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
Yuan TC; Veeramani S; Lin MF
Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
[TBL] [Abstract][Full Text] [Related]
9. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
[TBL] [Abstract][Full Text] [Related]
10. Brain malignancies: Glioblastoma and brain metastases.
Lah TT; Novak M; Breznik B
Semin Cancer Biol; 2020 Feb; 60():262-273. PubMed ID: 31654711
[TBL] [Abstract][Full Text] [Related]
11. SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.
Li Y; Donmez N; Sahinalp C; Xie N; Wang Y; Xue H; Mo F; Beltran H; Gleave M; Wang Y; Collins C; Dong X
Eur Urol; 2017 Jan; 71(1):68-78. PubMed ID: 27180064
[TBL] [Abstract][Full Text] [Related]
12. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
Godde NJ; Galea RC; Elsum IA; Humbert PO
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):149-68. PubMed ID: 20461450
[TBL] [Abstract][Full Text] [Related]
13. Differentiation and transdifferentiation potentials of cancer stem cells.
Huang Z; Wu T; Liu AY; Ouyang G
Oncotarget; 2015 Nov; 6(37):39550-63. PubMed ID: 26474460
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment.
Le Large TY; Mato Prado M; Krell J; Bijlsma MF; Meijer LL; Kazemier G; Frampton AE; Giovannetti E
Expert Rev Mol Diagn; 2016 Jul; 16(7):733-6. PubMed ID: 27118062
[TBL] [Abstract][Full Text] [Related]
15. Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.
Li CI; Zhang Y; Cieślik M; Wu YM; Xiao L; Cobain E; Tang MC; Cao X; Porter P; Guenthoer J; Robinson DR; Chinnaiyan AM
Clin Cancer Res; 2021 Jun; 27(11):3079-3093. PubMed ID: 33753452
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
17. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
[TBL] [Abstract][Full Text] [Related]
18. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
[TBL] [Abstract][Full Text] [Related]
19. Lineage plasticity in cancer: a shared pathway of therapeutic resistance.
Quintanal-Villalonga Á; Chan JM; Yu HA; Pe'er D; Sawyers CL; Sen T; Rudin CM
Nat Rev Clin Oncol; 2020 Jun; 17(6):360-371. PubMed ID: 32152485
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of microinvasive breast cancer microenvironment progression.
Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]